NAD+ infusion inquiries come in two flavors. The first-timer wants to know what the experience is actually like, having heard rumors about chest pressure and abdominal cramping during the drip. The repeat patient wants to know if they should step up from 500mg to 750mg, how the maintenance schedule should look after a 4-session starter series, and what the total cost commitment looks like. Both need answers that respect the time and money involved. NAD+ is not a $99 lunch break; it's a $599-$899 multi-hour commitment that needs preparation.

SleekAI maps your dose tiers (250mg starter, 500mg standard, 750mg, 1000mg high-dose), infusion rate guidance (typically 1-2 hours per 500mg to minimize side effects), the side effect mitigation playbook (slower drip, niacin pre-medication, anti-nausea options), and the package pricing for starter series and maintenance. When a first-timer asks what to expect, the bot quotes the 2-3 hour reality, the typical side effect profile (chest pressure, jaw tension, abdominal cramping at higher rates), and the mitigation steps your nurses use.

Generic chatbots either hype NAD+ as a miracle or refuse to engage. SleekAI reads your specific protocol and lets the bot speak with the same calm clinical accuracy your nurses use. Dose, rate, expected sensations, what to eat beforehand, what to bring (laptop, audiobook, snacks), bathroom timing during infusion, and whether the next session can be sooner than 72 hours. All quoted from your protocol page, all consistent with what the nurse will say in chair, all written to convert the curious into the booked without overpromising.

NAD+ is the wellness market's most overpromised infusion. Patients arrive expecting a recharge that takes thirty minutes and delivers a miracle. The reality is a 2-3 hour chair commitment with measurable but uncomfortable side effects at higher doses, a $1,499 starter series investment, and outcomes that vary substantially.

Clinics that overpromise lose patients on session two when the chair time and the chest pressure aren't what was sold. Clinics that underprepare lose patients on session one when the cramping surprises them. SleekAI lets your clinic set honest expectations from the first chat message.

The bot quotes the 90-minute starter dose accurately, explains chest pressure as a normal slowable-rate sensation rather than a danger, and helps the first-timer bring a laptop and a real meal so the experience matches the price tag. Repeat patients trust the maintenance recommendation because it tracks with their starter series experience. The medical director consult for cardiac or oncology patients happens because the bot routes correctly, not because the patient slipped through to the chair and had a reaction.

Generic chatbots can't read your protocol and end up describing NAD+ as fancy hydration. SleekAI reads your specific dose tiers, your specific side effect mitigation, your specific scheduling cadence, and lets the bot speak the same way your most experienced nurse would. Patients arrive prepared, the starter series completes at higher rates, maintenance signups follow because the math and the experience were honest, and your front desk stops repeating the same first-timer education thirty times a week.

The result is a clinic that scales without compromising the clinical conversation.